Register for research updates
Tell us how you relate to the programme. Registering opens your email client with a pre-filled message to the Panacea Bio Chem research team — nothing is collected on this page.
N-BX01™ is a research-stage candidate. There is no open clinical study at this time. When studies for the NBetaX™ nuclear β-catenin exclusion peptide become authorised and open for recruitment, official registration, phase and design, participating locations, eligibility, investigator contacts and results will be published here.
Tell us how you relate to the programme. Registering opens your email client with a pre-filled message to the Panacea Bio Chem research team — nothing is collected on this page.